Osafo, C.Morton, B.Ready, A.Jewitt-Harris, J.Adu, D.2019-07-092019-07-092018-04DOI: 10.1097/TP.0000000000002119Vol.102(4): pp 539-541http://ugspace.ug.edu.gh/handle/123456789/31323There is a growing burden of end-stage kidney disease (ESKD) in sub Saharan Africa, driven by a genetic predisposition to kidney disease and an increasing prevalence of hypertension and diabetes mellitus. It is estimated that 13.9% (95% confidence interval, 12.2-15.7) African Blacks have chronic kidney disease1 with a significant fraction progressing to ESKD, a harbinger of imminent death in Africa due to the scarcity and the lack of affordable dialysis. Kidney transplantation is the best treatment for ESKD, conferring superior survival, quality of life in addition to being more cost effective than dialysis.2 A recent systematic literature review in sub-Saharan Africa (excluding South Africa and Sudan) showed that only few adults (16 studies) and children (6 studies) received kidney transplants (1.1% and 2.5%, respectively).3 The report of The Transplantation Society meeting in 2013 emphasized the lack of kidney transplantation in sub-Saharan Africa.4enArticle